Boustead Secures Design-and-Build Contract for Pharmaceutical Facility
Summary:
-
Contract Awarded: Boustead Singapore Limited's Real Estate Solutions Division has secured a design-and-build contract for an integrated pharmaceutical manufacturing and R&D facility.
-
Location: The facility will be situated within Tuas Biomedical Park.
-
Purpose: The new facility aims to enhance the client's global network and meet growing demand in drug discoveries and treatments.
-
Completion Timeline: Expected by the third quarter of calendar year 2026.
-
Order Backlog Impact: This contract, along with a MYR300 million (~S$90 million) data centre project secured in Malaysia in November 2024, has increased the Real Estate Solutions Division’s order backlog to S$249 million and the Boustead Group’s engineering order backlog to S$428 million.
Note: All data is sourced from Boustead Singapore Limited's announcement dated 28 March 2025.